FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Evangelos Terpos

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Physiology

Bone Remodeling

Co-author Network

Publications

TOP 3
Theodora Psaltopoulou; Theodoros N Sergentanis; Evangelos Terpos; Prodromos Kanavidis; Nick Kanellias; Meletios A Dimopoulos
Tobacco smoking and risk of multiple myeloma: a meta-analysis of 40 observational studies.
Evangelos Terpos; G David Roodman; Meletios A Dimopoulos
Optimal use of bisphosphonates in patients with multiple myeloma.
Meletios A Dimopoulos; Evangelos Terpos; Efstathios Kastritis
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Evangelos Terpos (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Theodora Psaltopoulou; Theodoros N Sergentanis; Evangelos Terpos; Prodromos Kanavidis; Nick Kanellias; Meletios A Dimopoulos
Tobacco smoking and risk of multiple myeloma: a meta-analysis of 40 observational studies.
International journal of cancer. Journal international du cancer 2013;132(10):2413-31.
2013: Evangelos Terpos; G David Roodman; Meletios A Dimopoulos
Optimal use of bisphosphonates in patients with multiple myeloma.
Blood 2013;121(17):3325-8.
2013: Meletios A Dimopoulos; Evangelos Terpos; Efstathios Kastritis
Proteasome Inhibitor Therapy for Waldenström's Macroglobulinemia.
Clinical lymphoma, myeloma & leukemia 2013;13(2):235-7.
2013: Efstathios Kastritis; M Migkou; Lia A Moulopoulos; Maria Roussou; Maria Spyropoulou-Vlachou; Anna Tasidou; Evangelos Terpos; E Eleftherakis-Papaiakovou; M Gavriatopoulou; M Gkotzamanidou; N Kanellias; Meletios A Dimopoulos
Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease.
Leukemia 2013;27(4):947-53.
2013: Meletios A Dimopoulos; M Gkotzamanidou; Charis Matsouka; D Mparmparoussi; N Nikitas; Erasmia Psimenou; Maria Roussou; Maria Spyropoulou-Vlachou; Evangelos Terpos; Efstathios Kastritis
The role of novel agents on the reversibility of renal impairment in newly diagnosed symptomatic patients with multiple myeloma.
Leukemia 2013;27(2):423-9.
2013: Aristeidis Chaidos; Gillian Cowan; Meletios Dimopoulos; Helen Doolittle; Letizia Foroni; Heather Harrington; Evdoxia Hatjiharissi; Philippa C May; Valeria Melo; Kikkeri Naresh; Mary Papaioannou; Amin Rahemtulla; Alistair Reid; Irene Roberts; Michael Stumpf; Evangelos Terpos; Helen Yarranton; Saad Abdalla; Chris P Barnes; Anastasios Karadimitris
Clinical drug resistance linked to interconvertible phenotypic and functional states of tumor-propagating cells in multiple myeloma.
Blood 2013;121(2):318-28.
2013: Roger G Owen; Christopher J Patterson; Andy C Rawstron; Marvin J Stone; Alessandra Tedeschi; Evangelos Terpos; Steve P Treon; Kenneth C Anderson; Stephen M Ansell; Ramon Garcia-Sanz; Morie A Gertz; Irene M Ghobrial; Douglas E Joshua; Efstathios Kastritis; Eva Kimby; Robert A Kyle; Veronique Leblond; Xavier Leleu; Giampaolo Merlini; Pierre Morel; William G Morice; Enrica Morra; Nikhil C Munshi; Enrique M Ocio
Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop.
British journal of haematology 2013;160(2):171-6.
2013: Scott Z Fields; Abderrahmane Laadem; Shiroo Parshad; Haralambos Raftopoulos; Matthew L Sherman; Victoria Sung; Mark J Alexander; Madhurima Anne; Evangelos Terpos
Activin receptor antagonists for cancer-related anemia and bone disease.
Expert opinion on investigational drugs 2013;22(1):87-101.
2013: Stergios A Polyzos; Efthimia Zafeiriadou; Christos Zavos; Kyriaki Anastasiadou; Evangelia Katsiki; Jannis Kountouras; Athanasios Papatheodorou; Kalliopi Patsiaoura; Evangelos Terpos
Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.
Metabolism: clinical and experimental 2013;62(1):121-6.
2012: Evangelos Terpos; Efstathios Kastritis; Meletios A Dimopoulos
Prevention and treatment of myeloma bone disease.
Current hematologic malignancy reports 2012;7(4):249-57.
2012: Meletios A Dimopoulos; Hartmut Goldschmidt; Tomer Mark; Adrian Alegre; Evangelos Terpos; Ruben Niesvizky
Treatment with lenalidomide and dexamethasone in patients with multiple myeloma and renal impairment.
Cancer treatment reviews 2012;38(8):1012-9.
2012: Maurizio Zangari; Fenghuang Zhan; Evangelos Terpos; Guido Tricot
Impact of bortezomib on bone health in myeloma: a review of current evidence.
Cancer treatment reviews 2012;38(8):968-80.
2012: N G Gavalas; Dimitrios Haidopoulos; K Ioannou; E Politi; Alexandros Rodolakis; Evangelos Terpos; Nikolaos Thomakos; Marinos L Tsiatas; Ourania E Tsitsilonis; George Vlahos; A C Ziogas; A Antsaklis; Meletios A Dimopoulos; Aristotelis Bamias
VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2.
British journal of cancer 2012;107(11):1869-75.
2012: Evangelos Terpos; Efstathios Kastritis; Michel Rybojad; Bouchra Asli; Djaouida Bengoufa; Jean-Claude Brouet; Dimitrios Christoulas; Meletios A Dimopoulos; Jean-Paul Fermand
Increased angiogenesis and enhanced bone formation in patients with IgM monoclonal gammopathy and urticarial skin rash: new insight into the biology of Schnitzler syndrome.
Haematologica 2012;97(11):1699-703.
2012: Ersi Voskaridou; A D Anastasilakis; C Bratengeier; D Christoulas; Maria N Dimopoulou; M Gkotzamanidou; D Kaliontzi; Veroniki Komninaka; E Plata; S A Polyzos; Evangelos Terpos
High circulating sclerostin is present in patients with thalassemia-associated osteoporosis and correlates with bone mineral density.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2012;44(12):909-13.
2012: Evangelos Terpos; D Christoulas; E Eleutherakis-Papaiakovou; M Gkotzamanidou; N Kanellias; Efstathios Kastritis; Athanasios Papatheodorou; Meletios A Dimopoulos
Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival; no alterations post-lenalidomide and dexamethasone therapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(10):2681-6.
2012: Evangelos Terpos; Konstantinos Zervas; Cornelia Bratengeier; Dimitrios Christoulas; Sosana Delimpasi; Maria Gkotzamanidou; Efstathios Kastritis; Eirini Katodritou; John Meletis; Eurydiki Michalis; Anastasia Pouli; Meletios A Dimopoulos
Elevated circulating sclerostin correlates with advanced disease features and abnormal bone remodeling in symptomatic myeloma: reduction post-bortezomib monotherapy.
International journal of cancer. Journal international du cancer 2012;131(6):1466-71.
2012: Lia A Moulopoulos; Maria Roussou; Dimitrios Christoulas; Meletios A Dimopoulos; Evangelos Eleutherakis-Papaiakovou; Maria Gavriatopoulou; Dimitra Gika; Maria Gkotzamanidou; Efstathios Kastritis; Andreas Koureas; Vassilios Koutoulidis; Magdalini Migkou; Evangelos Terpos
Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients.
American journal of hematology 2012;87(9):861-4.
2012: Maria Gkotzamanidou; Efstathios Kastritis; Lia A Moulopoulos; Dimitrios Christoulas; Meletios A Dimopoulos; Evangelos Terpos
Sclerostin: a possible target for the management of cancer-induced bone disease.
Expert opinion on therapeutic targets 2012;16(8):761-9.
2012: Anna Tasidou; Evangelos Terpos; Dimitra Anagnostou; Evangelos Eleutherakis-Papaiakovou; Maria Gavriatopoulou; Maria Gkotzamanidou; Efstathios Kastritis; Magdalini Migkou; Nikitas Nikitas; Maria Roussou; Meletios A Dimopoulos
Increased expression of cyclin-D1 on trephine bone marrow biopsies independently predicts for shorter overall survival in patients with multiple myeloma treated with novel agents.
American journal of hematology 2012;87(7):734-6.
2012: Meletios A Dimopoulos; Dimitra Gika; Evdoxia Hatjiharissi; Eleftheria C Hatzimichael; Zafiris Kartasis; Efstathios Kastritis; Eirini Katodritou; Marie-Christine Kyrtsonis; Michalis Michael; Evridiki Michalis; Agapi Parcharidou; Panayiotis Repousis; Ekaterini Stefanoudaki; Argyris Symeonidis; Evangelos Terpos; Costas Tsatalas; Maria Tsirogianni; Konstantinos Zervas; Sossana Delimpasi
Multiple myeloma in octogenarians: clinical features and outcome in the novel agent era.
European journal of haematology 2012;89(1):10-5.
2012: Efstathios Kastritis; Smaragda Marinaki; Evridiki Michalis; Nikitas Nikitas; Constantinos Pamboukas; Maria Roussou; Evangelos Terpos; Theofanis Apostolou; Ioannis Boletis; Sossana Delimpasi; Maria Gavriatopoulou; Georgios Gkortzolidis; Meletios A Dimopoulos
A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis.
Blood 2012;119(23):5384-90.
2012: Ersi Voskaridou; Dimitrios Christoulas; Evangelos Terpos
Sickle-cell disease and the heart: review of the current literature.
British journal of haematology 2012;157(6):664-73.
2012: Martina Kleber; Barbara Metzke; Gareth Morgan; G David Roodmann; Evangelos Terpos; Josefina Udi; Ralph Wäsch; Angela Dispenzieri; Hermann Einsele; Monika Engelhardt
Challenging the current approaches to multiple myeloma- and other cancer-related bone diseases: from bisphosphonates to targeted therapy.
Leukemia & lymphoma 2012;53(6):1057-61.
2012: Polyzois Makras; Athanasios Papatheodorou; Evangelos Terpos; Athanasios D Anastasilakis; George Kanakis; Panagiotis Kokkoris; Gregory A Kaltsas
Reduced bone mineral density in adult patients with Langerhans cell histiocytosis.
Pediatric blood & cancer 2012;58(5):819-22.
2012: Polyzois Makras; Athanasios Papatheodorou; Stergios A Polyzos; Marian Schini; Evangelos Terpos; Athanasios D Anastasilakis; George Kanakis; Gregory A Kaltsas
Serum osteoprotegerin, RANKL, and Dkk-1 levels in adults with Langerhans cell histiocytosis.
The Journal of clinical endocrinology and metabolism 2012;97(4):E618-21.
2012: Meletios A Dimopoulos; Dimitra Gika; Zafiris Kartasis; Efstathios Kastritis; Kostas Konstantopoulos; M Michael; Evridiki Michalis; Agapi Parcharidou; Anastasia Pouli; Maria Roussou; Evangelos Terpos; Costas Tsatalas; Konstantinos Zervas; Athanasios Zomas; S Delimpasi
The International Scoring System (ISS) for multiple myeloma remains a robust prognostic tool independently of patients' renal function.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(3):722-9.
2012: S A Polyzos; A D Anastasilakis; C Bratengeier; A Papatheodorou; W Woloszczuk; Evangelos Terpos
Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women--the six-month effect of risedronate and teriparatide.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2012;23(3):1171-6.
2012: Evangelos Terpos
Bisphosphonate anticancer activity in multiple myeloma.
Anti-cancer agents in medicinal chemistry 2012;12(2):123-8.
2012: Stergios A Polyzos; Panagiotis Anagnostis; Athanasios D Anastasilakis; Georgios Arsos; Marina Kita; Efstratios Moralidis; Athanasios Papatheodorou; Evangelos Terpos
Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.
Endokrynologia Polska 2012;63(4):312-5.
2012: Theodoros P Vassilakopoulos; Effimia Vrakidou; Alexandra Zorbala; Photis Beris; Nikos Constantinou; John Dervenoulas; Evangelia M Dimitriadou; Meletios A Dimopoulos; Maria N Dimopoulou; Zacharoula Galani; Christina Kalpadakis; Andreas Katsigiannis; Styliani Kokoris; Marie-Christine Kyrtsonis; John Meletis; Panayiotis Panayiotidis; Gerassimos A Pangalis; Sotirios G Papageorgiou; Christos Poziopoulos; Panagiotis Repoussis; Paraskevi Roussou; Sotirios Sachanas; Marina P Siakantaris; Evangelos Terpos; Maria K Angelopoulou
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care.
The oncologist 2012;17(2):239-49.
2011: Evangelos Eleftherakis-Papapiakovou; Maria Gkotzamanidou; Irini Grapsa; Efstathios Kastritis; Nikitas Nikitas; Erasmia Psimenou; Maria Roussou; Evangelos Terpos; Meletios A Dimopoulos
Renal impairment is not an independent adverse prognostic factor in patients with multiple myeloma treated upfront with novel agent-based regimens.
Leukemia & lymphoma 2011;52(12):2299-303.
2011: Eirini Katodritou; panos kottaridis; Christina Chadjiaggelidou; Vasiliki Gastari; Samuel Jide-Banwo; Dimitrios Kapetanos; Janet North; Shivajanani Sivakumaran; Evangelos Terpos; Maria Tsirogianni; Evgenia Verrou; Konstantinos Zervas; Mark W Lowdell
Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells.
American journal of hematology 2011;86(12):967-73.
2011: Robert Coleman; Richard Cook; Luis Costa; Meletios Dimopoulos; Patrick Garnero; Peyman Hadji; Ker-Ai Lee; Pierre Major; Fred Saad; Matthew Smith; Evangelos Terpos; Jean-Jacques Body; Janet Brown; Allan Lipton
Consensus on the utility of bone markers in the malignant bone disease setting.
Critical reviews in oncology/hematology 2011;80(3):411-32.
2011: Magdalini Migkou; Evangelos Terpos; Meletios A Dimopoulos; Maria Gkotzamanidou; Efstathios Kastritis
Response to bortezomib of a patient with scleromyxedema refractory to other therapies.
Leukemia research 2011;35(11):e209-11.
2011: Nikolaos C Giannakoulas; Polixeni Lampropoulou; Maria Palassopoulou; Argyris Symeonidis; Evangelos Terpos; Vasiliki Zolota; Panagiota Matsouka
Increased RANKL and IL-6 levels might result in high bone turnover in a case of a CD34+/CD117+/myeloperoxidase(+dim) acute myeloid leukemia presenting with severe hypercalcemia and lumbar spine fractures.
Leukemia research 2011;35(11):e188-9.
2011: Giannis Mountzios; Vassilis Ramfidis; Evangelos Terpos; Konstantinos N Syrigos
Prognostic significance of bone markers in patients with lung cancer metastatic to the skeleton: a review of published data.
Clinical lung cancer 2011;12(6):341-9.
2011: Antonio Palumbo; Laura Rosiñol; Jesus F San Miguel; Orhan Sezer; Andrew Spencer; Evangelos Terpos; Sonja Zweegman; Meral Beksac; Joan Bladé; Mario Boccadoro; Sara Bringhen; Michele Cavo; Faith Davies; Meletios A Dimopoulos; Christoph Driessen; Hermann Einsele; Peter Gimsing; Martin Gramatzki; Roman Hàjek; Hans E Johnsen; Fernando Leal Da Costa; Henk Lokhorst; Heinz Ludwig; Maria V Mateos; Gareth Morgan; Pieter Sonneveld
Personalized therapy in multiple myeloma according to patient age and vulnerability: a report of the European Myeloma Network (EMN).
Blood 2011;118(17):4519-29.
2011: Maria Gkotzamanidou; Efstathios Kastritis; Charis Matsouka; Despina Mparmparousi; Nikitas Nikitas; Evangelos Terpos; Maria Roussou Magdalini Migkou Maria Gavriatopoulou; Dimitra Gika; Meletios A Dimopoulos
Increased serum lactate dehydrongenase should be included among the variables that define very-high-risk multiple myeloma.
Clinical lymphoma, myeloma & leukemia 2011;11(5):409-13.
2011: Flora Zagouri; Maria Gavriatopoulou; Maria Gkotzamanidou; Efstathios Kastritis; Andreas Koureas; Magdalini Migkou; Nikitas Nikitas; Maria Roussou; Evangelos Terpos; Eleni Tsokou; Meletios-Athanasios Dimopoulos
Lenalidomide-associated pneumonitis in patients with plasma cell dyscrasias.
American journal of hematology 2011;86(10):882-4.
2011: Esperanza Such; Evangelos Terpos; Amparo Avaria; José V Bagán; José Cervera; Lourdes Cordón; Meletios A Dimopoulos; Inés Gómez; Mariam Ibañez; Irene Luna; María Margaix; Mónica Roig; Miguel A Sanz; Javier de la Rubia
CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.
Haematologica 2011;96(10):1557-9.
2011: Magdalini Migkou; Despina Mparmparoussi; Nikitas Nikitas; Maria Roussou; Evangelos Terpos; Maria Gavriatopoulou; Dimitra Gika; Maria Gkotzamanidou; Efstathios Kastritis; Charis Matsouka; Meletios A Dimopoulos
Short progression-free survival predicts for poor overall survival in older patients with multiple myeloma treated upfront with novel agent-based therapy.
European journal of haematology 2011;87(4):323-9.
2011: Meletios A Dimopoulos; Evangelos Terpos
Advances in the treatment of multiple myeloma.
European journal of cancer (Oxford, England : 1990) 2011;47 Suppl 3():S306-8.
2011: Ersi Voskaridou; Dimitrios Christoulas; Evangelos Terpos
Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies.
British journal of haematology 2011;154(5):654-6.
2011: Efstathios Kastritis; Marie-Christine Kyrtsonis; Evdoxia Hatjiharissi; Argyris Symeonidis; Evridiki Michalis; Panagiotis Repoussis; Konstantinos Tsatalas; Michael Michael; Anastasia Sioni; Zafiris Kartasis; Ekaterini Stefanoudaki; Michael Voulgarelis; Sosana Delimpasi; Maria Gavriatopoulou; Efstathios Koulieris; Dimitra Gika; Elissavet Vervesou; Kostas Konstantopoulos; Garyfalia Kokkini; Athanasios Zomas; Paraskevi Roussou; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Evangelos Terpos; Konstantinos Zervas; Meletios A Dimopoulos
No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years.
American journal of hematology 2011;86(6):479-83.
2011: Evangelos Terpos; Lia A Moulopoulos; Meletios A Dimopoulos
Advances in imaging and the management of myeloma bone disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(14):1907-15.
2011: Michel Delforge; Evangelos Terpos; Paul G Richardson; Ofer Shpilberg; Nuriet K Khuageva; Rudolf Schlag; Meletios A Dimopoulos; Martin Kropff; Ivan Spicka; Maria T Petrucci; Olga S Samoilova; Maria-Victoria Mateos; Hila Magen-Nativ; Hartmut Goldschmidt; Dixie Esseltine; Deborah S Ricci; Kevin Liu; William Deraedt; Andrew Cakana; Helgi van de Velde; Jesús F San Miguel
Fewer bone disease events, improvement in bone remodeling, and evidence of bone healing with bortezomib plus melphalan-prednisone vs. melphalan-prednisone in the phase III VISTA trial in multiple myeloma.
European journal of haematology 2011;86(5):372-84.
2011: Sandra Grass; Klaus-Dieter Preuss; Alexandra Wikowicz; Evangelos Terpos; Marita Ziepert; Diana Nikolaus; Yin Yang; Natalie Fadle; Evi Regitz; Meletios A Dimopoulos; Steven P Treon; Zachary R Hunter; Michael Pfreundschuh
Hyperphosphorylated paratarg-7: a new molecularly defined risk factor for monoclonal gammopathy of undetermined significance of the IgM type and Waldenstrom macroglobulinemia.
Blood 2011;117(10):2918-23.
2011: Efstathios Kastritis; Evangelos Terpos; Meletios A Dimopoulos
Emerging drugs for Waldenström's macroglobulinemia.
Expert opinion on emerging drugs 2011;16(1):45-57.
2011: Evangelos Terpos; Meletios A Dimopoulos
Interaction between the skeletal and immune systems in cancer: mechanisms and clinical implications.
Cancer immunology, immunotherapy : CII 2011;60(3):305-17.
2011: Evangelos Terpos
The synergistic effect of panobinostat (LBH589) with melphalan or doxorubicin on multiple myeloma cells; rationale for the use of combination regimens in myeloma patients.
Leukemia research 2011;35(3):295-6.
2011: Efstathios Kastritis; Maria Gavriatopoulou; Marie-Christine Kyrtsonis; Michael Michael; Evdoxia Hadjiharissi; Argyris Symeonidis; Evridiki Michalis; Panagiotis Repoussis; Konstantinos Tsatalas; Anastasia Sioni; Zafiris Kartasis; Ekaterini Stefanoudaki; Michael Voulgarelis; Sosana Delimpasi; Dimitra Gika; Elissavet Vervesou; Konstantinos Konstantopoulos; Garyfalia Kokkini; Athanasios Zomas; Paraskevi Roussou; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Evangelos Terpos; Konstantinos Zervas; Meletios A Dimopoulos
Prognostication of the high-risk WM patient.
Clinical lymphoma, myeloma & leukemia 2011;11(1):127-9.
2011: Evangelos Terpos; Anna Tasidou; Evangelos Eleftherakis-Papaiakovou; Dimitrios Christoulas; Maria Gavriatopoulou; Maria Gkotzamanidou; Maria Roussou; Efstathios Kastritis; Theodora Papadaki; Meletios-Athanassios Dimopoulos
Expression of CCL3 by neoplastic cells in patients with Waldenström's macroglobulinemia: an immunohistochemical study in bone marrow biopsies of 67 patients.
Clinical lymphoma, myeloma & leukemia 2011;11(1):115-7.
2011: Evangelos Terpos; Meletios A Dimopoulos; James Berenson
Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease.
Critical reviews in oncology/hematology 2011;77 Suppl 1():S13-23.
2011: Evangelos Terpos
Zoledronic acid: a framework of emerging anticancer evidence throughout the cancer continuum.
Critical reviews in oncology/hematology 2011;77 Suppl 1():S1-2.
2011: Antonis Skliris; Kaisa E Happonen; Evangelos Terpos; Vassiliki Labropoulou; Magne Børset; Dick Heinegård; Anna M Blom; Achilleas D Theocharis
Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
European journal of immunology 2011;41(2):437-49.
2011: Ersi Voskaridou; Eleni Plata; Marousa Douskou; Anastasia Sioni; Efrosini Mpoutou; Dimitrios Christoulas; Maria Dimopoulou; Evangelos Terpos
Deferasirox effectively decreases iron burden in patients with double heterozygous HbS/β-thalassemia.
Annals of hematology 2011;90(1):11-5.
2011: S A Polyzos; Jannis Kountouras; A D Anastasilakis; I Litsas; M Kita; Georgios Arsos; Efstratios Moralidis; Evangelos Terpos
Zoledronic acid-induced transient hepatotoxicity in a patient effectively treated for Paget's disease of bone.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2011;22(1):363-7.
2010: Meletios A Dimopoulos; Evangelos Terpos; Asher Chanan-Khan; Nelson Leung; Heinz Ludwig; Sundar Jagannath; Ruben Niesvizky; Sergio Giralt; Jean-Paul Fermand; Joan Bladé; Raymond L Comenzo; Orhan Sezer; Antonio Palumbo; Jean-Luc Harousseau; Paul G Richardson; Bart Barlogie; Kenneth C Anderson; Pieter Sonneveld; Patrizia Tosi; Michele Cavo; S Vincent Rajkumar; Brian G M Durie; Jésus San Miguel
Renal impairment in patients with multiple myeloma: a consensus statement on behalf of the International Myeloma Working Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(33):4976-84.
2010: Meletios-Athanassios Dimopoulos; Evangelos Terpos
Lenalidomide: an update on evidence from clinical trials.
Blood reviews 2010;24 Suppl 1():S21-6.
2010: Evangelos Eleutherakis-Papaiakovou; Evangelos Kostis; Magda Migkou; Dimitrios Christoulas; Evangelos Terpos; Maria Gavriatopoulou; Maria Roussou; Evangelos Bournakis; Efstathios Kastritis; Eleni Efstathiou; Meletios A Dimopoulos; Christos A Papadimitriou
Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
American journal of hematology 2010;85(11):863-7.
2010: Gina Zini; Barbara Bain; Peter Bettelheim; José Cortez; Giuseppe d'Onofrio; Edgar Faber; Torsten Haferlach; Petra Kacirkova; Krzysztof Lewandowski; Estella Matutes; Marc Maynadié; John Meletis; Bodil L Petersen; Anna Porwit; Evangelos Terpos; Andrée Tichelli; Teresa Vallespí; Soledad Woessner; John Bennett; Marie C Bene
A European consensus report on blood cell identification: terminology utilized and morphological diagnosis concordance among 28 experts from 17 countries within the European LeukemiaNet network WP10, on behalf of the ELN Morphology Faculty.
British journal of haematology 2010;151(4):359-64.
2010: Monika Engelhardt; Josefina Udi; Martina Kleber; Andrew Spencer; Alberto Rocci; Stefan Knop; Benedetto Bruno; Sara Bringhen; José A Pérez-Simón; Sonja Zweegman; Christoph Driessen; Francesca Patriarca; Martin Gramatzki; Evangelos Terpos; Orhan Sezer; Martin Kropff; Christian Straka; Hans E Johnsen; Anders Waage; Martin Boegsted; Henk Lokhorst; Roman Hájek; Gareth Morgan; Mario Boccadoro; Heinz Ludwig; Michele Cavo; Aaron Polliack; Pieter Sonneveld; Hermann Einsele; Antonio Palumbo
European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma.
Leukemia & lymphoma 2010;51(11):2006-11.
2010: Stergios A Polyzos; Athanasios D Anastasilakis; Ioannis Litsas; Zoe Efstathiadou; Marina Kita; Georgios Arsos; Efstratios Moralidis; Athanasios Papatheodorou; Evangelos Terpos
Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease.
Journal of bone and mineral metabolism 2010;28(6):706-12.
2010: Meletios A Dimopoulos; Evangelos Terpos
Multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21 Suppl 7():vii143-50.
2010: Evangelos Terpos; Meletios A Dimopoulos
Intravenous pamidronate for myeloma bone disease: can the dose be lowered?
The lancet oncology 2010;11(10):913-4.
2010: Evangelos Terpos; Meletios A Dimopoulos; O Sezer; D Roodman; N Abildgaard; R Vescio; P Tosi; R Garcia-Sanz; F Davies; A Chanan-Khan; Antonio Palumbo; Pieter Sonneveld; M T Drake; Jean-Luc Harousseau; Kenneth C Anderson; B G M Durie
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working Group.
Leukemia 2010;24(10):1700-12.
2010: Meletios A Dimopoulos; Efstathios Kastritis; D Christoulas; M Migkou; M Gavriatopoulou; M Gkotzamanidou; M Iakovaki; Charis Matsouka; D Mparmparoussi; Maria Roussou; Eleni Efstathiou; Evangelos Terpos
Treatment of patients with relapsed/refractory multiple myeloma with lenalidomide and dexamethasone with or without bortezomib: prospective evaluation of the impact of cytogenetic abnormalities and of previous therapies.
Leukemia 2010;24(10):1769-78.
2010: Maria Roussou; Efstathios Kastritis; Dimitrios Christoulas; Magdalini Migkou; Maria Gavriatopoulou; Irini Grapsa; Erasmia Psimenou; Dimitra Gika; Evangelos Terpos; Meletios A Dimopoulos
Reversibility of renal failure in newly diagnosed patients with multiple myeloma and the role of novel agents.
Leukemia research 2010;34(10):1395-7.
2010: Efstathios Kastritis; Marie-Christine Kyrtsonis; Evdoxia Hadjiharissi; Argyris Symeonidis; Evridiki Michalis; Panagiotis Repoussis; Costas Tsatalas; Michael Michael; Anastasia Sioni; Zafiris Kartasis; Ekaterini Stefanoudaki; Michael Voulgarelis; Sossana Delimpasi; Maria Gavriatopoulou; Efstathios Koulieris; Dimitra Gika; Athanasios Zomas; Paraskevi Roussou; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Evangelos Terpos; Konstantinos Zervas; Meletios A Dimopoulos
Validation of the International Prognostic Scoring System (IPSS) for Waldenstrom's macroglobulinemia (WM) and the importance of serum lactate dehydrogenase (LDH).
Leukemia research 2010;34(10):1340-3.
2010: Efstathios Kastritis; Maria Roussou; Michalis Michael; Maria Gavriatopoulou; Evridiki Michalis; Magdalini Migkou; Sossana Delimpasi; Marie-Christine Kyrtsonis; Dimitrios Gogos; Konstantinos Liapis; Evangelia Charitaki; Panagiotis Repousis; Evangelos Terpos; Meletios A Dimopoulos
High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients.
British journal of haematology 2010;150(5):587-91.
2010: Evangelos Terpos; Ersi Voskaridou
Treatment options for thalassemia patients with osteoporosis.
Annals of the New York Academy of Sciences 2010;1202():237-43.
2010: Evangelos Terpos; Eirini Katodritou; Maria Roussou; Anastasia Pouli; Evridiki Michalis; Sosana Delimpasi; Agapi Parcharidou; Zafiris Kartasis; Athanasios Zomas; Argyris Symeonidis; Nora Viniou; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Konstantinos Zervas; Meletios A Dimopoulos
High serum lactate dehydrogenase adds prognostic value to the international myeloma staging system even in the era of novel agents.
European journal of haematology 2010;85(2):114-9.
2010: Evangelos Terpos; D Christoulas; P Kokkoris; Konstantinos Anargyrou; M Gavriatopoulou; M Migkou; Konstantinos Tsionos; Meletios A Dimopoulos
Increased bone mineral density in a subset of patients with relapsed multiple myeloma who received the combination of bortezomib, dexamethasone and zoledronic acid.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(7):1561-2.
2010: Meletios A Dimopoulos; Dimitrios Christoulas; Maria Roussou; Efstathios Kastritis; Magdalini Migkou; Maria Gavriatopoulou; Charis Matsouka; Despoina Mparmparoussi; Erasmia Psimenou; Irini Grapsa; Eleni Efstathiou; Evangelos Terpos
Lenalidomide and dexamethasone for the treatment of refractory/relapsed multiple myeloma: dosing of lenalidomide according to renal function and effect on renal impairment.
European journal of haematology 2010;85(1):1-5.
2010: L A Moulopoulos; Meletios A Dimopoulos; D Christoulas; Efstathios Kastritis; Dimitra Anagnostou; Andreas Koureas; Maria Roussou; M Gavriatopoulou; M Migkou; M Iakovaki; M Gkotzamanidou; Anna Tasidou; Evangelos Terpos
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents.
Leukemia 2010;24(6):1206-12.
2010: Athanasios D Anastasilakis; Stergios A Polyzos; Avraam Avramidis; Konstantinos A Toulis; Athanasios Papatheodorou; Evangelos Terpos
The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis.
Clinical endocrinology 2010;72(6):752-7.
2010: Eleni Karapanagiotou; Evangelos Terpos; Kalliopi D Dilana; Christina Alamara; Ioannis Gkiozos; Aris Polyzos; Konstantinos N Syrigos
Serum bone turnover markers may be involved in the metastatic potential of lung cancer patients.
Medical oncology (Northwood, London, England) 2010;27(2):332-8.
2010: Giannis Mountzios; Evangelos Terpos; Konstantinos SYRIGOS; Christos Papadimitriou; George Papadopoulos; Aristotelis Bamias; Myron Mavrikakis; Meletios-Athanassios Dimopoulos
Markers of bone remodeling and skeletal morbidity in patients with solid tumors metastatic to the skeleton receiving the biphosphonate zoledronic acid.
Translational research : the journal of laboratory and clinical medicine 2010;155(5):247-55.
2010: Evangelos Terpos; J Berenson; R J Cook; Allan Lipton; R E Coleman
Prognostic variables for survival and skeletal complications in patients with multiple myeloma osteolytic bone disease.
Leukemia 2010;24(5):1043-9.
2010: Stergios A Polyzos; Athanasios D Anastasilakis; Zoe Efstathiadou; Ioannis Litsas; Marina Kita; Athanasios Panagiotou; Athanasios Papatheodorou; Georgios Arsos; Efstratios Moralidis; Georgios Barmpalios; Efthimia Zafeiriadou; Efthimia Triantafillidou; Eleni Makrigiannaki; Evangelos Terpos
Serum homocysteine, folate and vitamin B12 in patients with Paget's disease of bone: the effect of zoledronic acid.
Journal of bone and mineral metabolism 2010;28(3):314-9.
2010: Stergios A Polyzos; Athanasios D Anastasilakis; Ioannis Litsas; Michail Sapranidis; Zoe Efstathiadou; Marina Kita; Georgios Arsos; Efstratios Moralidis; Efthimia Zafeiriadou; Athanasios Papatheodorou; Evangelos Terpos
Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1.
Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry 2010;13(2):190-6.
2010: Nikolaos J Tsagarakis; Nektaria A Kentrou; Konstantinos Papadimitriou; Maria Pagoni; Garyfallia Kokkini; Helen Papadaki; Vassiliki Pappa; Theodoros Marinakis; Nikolaos I Anagnostopoulos; Chrissanthi Vadikolia; Achilleas Anagnostopoulos; Maria K Angelopoulou; Evangelos Terpos; Christos Poziopoulos; Konstantinos Anargyrou; DEMETRA RONTOGIANNI; Theodora Papadaki; Aikaterini Psarra; Flora N Kontopidou; Dimitra Skoumi; Stefanos I Papadhimitriou; Georgios Paterakis
Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group.
Leukemia research 2010;34(4):438-46.
2010: Ersi Voskaridou; Dimitrios Christoulas; Antonios Bilalis; Eleni Plata; Konstantinos Varvagiannis; George Stamatopoulos; Klio Sinopoulou; Aggeliki Balassopoulou; Dimitris Loukopoulos; Evangelos Terpos
The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS).
Blood 2010;115(12):2354-63.
2010: Evangelos Terpos; Meletios A Dimopoulos; Vikas Shrivastava; Kim Leitzel; Dimitrios Christoulas; Magdalini Migkou; Maria Gavriatopoulou; Konstantinos Anargyrou; Peter Hamer; Efstathios Kastritis; Walter Carney; Allan Lipton
High levels of serum TIMP-1 correlate with advanced disease and predict for poor survival in patients with multiple myeloma treated with novel agents.
Leukemia research 2010;34(3):399-402.
2010: George Bozas; Evangelos Terpos; Dimitra Gika; Alexandra Karadimou; Meletios A Dimopoulos; Aristotelis Bamias
Prechemotherapy serum levels of CD105, transforming growth factor beta2, and vascular endothelial growth factor are associated with prognosis in patients with advanced epithelial ovarian cancer treated with cytoreductive surgery and platinum-based chemotherapy.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2010;20(2):248-54.
2010: Meletios A Dimopoulos; Evangelos Terpos
Renal insufficiency and failure.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2010;2010():431-6.
2010: Aristotle Bamias; Evangelos Terpos; Meletios A Dimopoulos
Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
Onkologie 2010;33(6):288-9.
2010: Ersi Voskaridou; Eleni Plata; Maroussa Douskou; Manousos Papadakis; Eleni-Evangelia Delaki; Dimitrios Christoulas; Evangelos Terpos
Treatment with deferasirox (Exjade) effectively decreases iron burden in patients with thalassaemia intermedia: results of a pilot study.
British journal of haematology 2010;148(2):332-4.
2010: Konstantinos Anargyrou; Theodoros P Vassilakopoulos; Maria K Angelopoulou; Evangelos Terpos
Incorporating novel agents in the treatment of myelodysplastic syndromes.
Leukemia research 2010;34(1):6-17.
2010: Olga Katsarou; Anna Kouramba; Stefanos Provelengios; Evangelos Terpos; Theophanis Adraktas; Pantelis Chatzismalis; Dimitrios Hadjidakis; Anastasia Karafoulidou
Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection.
Annals of hematology 2010;89(1):67-74.
2009: Christian Jakob; Andrea Goerke; Evangelos Terpos; Jan Sterz; Ulrike Heider; Dagmar Kühnhardt; Susanne Ziefle; Lorenz Kleeberg; Maren Mieth; Ivana von Metzler; Christian Müller; Orhan Sezer
Serum levels of total-RANKL in multiple myeloma.
Clinical lymphoma & myeloma 2009;9(6):430-5.
2009: Meletios A Dimopoulos; Evangelos Terpos
Hematology: first-line bortezomib benefits patients with multiple myeloma.
Nature reviews. Clinical oncology 2009;6(12):683-5.
2009: Eirini Katodritou; Meletios A Dimopoulos; Konstantinos Zervas; Evangelos Terpos
Update on the use of erythropoiesis-stimulating agents (ESAs) for the management of anemia of multiple myeloma and lymphoma.
Cancer treatment reviews 2009;35(8):738-43.
2009: Maria Roussou; Anna Tasidou; Meletios A Dimopoulos; Efstathios Kastritis; M Migkou; D Christoulas; M Gavriatopoulou; F Zagouri; Charis Matsouka; D Anagnostou; Evangelos Terpos
Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma.
Leukemia 2009;23(11):2177-81.
2009: Stergios A Polyzos; Athanasios D Anastasilakis; Evangelos Terpos
Transient secondary hyperparathyroidism following intravenous infusion of zoledronic acid.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2009;17(10):1329-30.
2009: A D Anastasilakis; K A Toulis; Dimitrios G Goulis; S A Polyzos; S Delaroudis; A Giomisi; Evangelos Terpos
Efficacy and safety of denosumab in postmenopausal women with osteopenia or osteoporosis: a systematic review and a meta-analysis.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2009;41(10):721-9.
2009: Meletios-Athanassios Dimopoulos; Lia A Moulopoulos; Evangelos Terpos
A new pet for myeloma.
Blood 2009;114(10):2007-8.
2009: Dimitrios Christoulas; Evangelos Terpos; Meletios A Dimopoulos
Pathogenesis and management of myeloma bone disease.
Expert review of hematology 2009;2(4):385-98.
2009: Meletios A Dimopoulos; Maria Roussou; Maria Gavriatopoulou; Flora Zagouri; Magdalini Migkou; Charis Matsouka; Despina Barbarousi; Dimitrios Christoulas; Erasmia Primenou; Irini Grapsa; Evangelos Terpos; Efstathios Kastritis
Reversibility of renal impairment in patients with multiple myeloma treated with bortezomib-based regimens: identification of predictive factors.
Clinical lymphoma & myeloma 2009;9(4):302-6.
2009: Athanasios D Anastasilakis; Konstantinos A Toulis; Stergios A Polyzos; Evangelos Terpos
RANKL inhibition for the management of patients with benign metabolic bone disorders.
Expert opinion on investigational drugs 2009;18(8):1085-102.
2009: Eirini Katodritou; Tomas Ganz; Evangelos Terpos; Evgenia Verrou; Gordana Olbina; Vassiliki Gastari; Christina Hadjiaggelidou; Maria Varthaliti; Sofia Georgiadou; Mark Westerman; Konstantinos Zervas
Sequential evaluation of serum hepcidin in anemic myeloma patients: study of correlations with myeloma treatment, disease variables, and anemia response.
American journal of hematology 2009;84(8):524-6.
2009: Evangelos Terpos; O Sezer; P I Croucher; R García-Sanz; Mario Boccadoro; J San Miguel; J Ashcroft; J Bladé; M Cavo; M Delforge; Meletios A Dimopoulos; T Facon; M Macro; A Waage; Pieter Sonneveld
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma Network.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(8):1303-17.
2009: Maria Gavriatopoulou; Meletios-Athanasios Dimopoulos; Dimitrios Christoulas; Magdalini Migkou; Marina Iakovaki; Maria Gkotzamanidou; Evangelos Terpos
Dickkopf-1: a suitable target for the management of myeloma bone disease.
Expert opinion on therapeutic targets 2009;13(7):839-48.
2009: Efstathios Kastritis; Konstantinos Zervas; Argyris Symeonidis; Evangelos Terpos; S Delimbassi; Nikolaos Anagnostopoulos; Evridiki Michali; Athanasios Zomas; Eirini Katodritou; Dimitra Gika; Anastasia Pouli; D Christoulas; Maria Roussou; Z Kartasis; Theofanis Economopoulos; Meletios A Dimopoulos
Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG).
Leukemia 2009;23(6):1152-7.
2009: Evangelos Terpos; Maria Kiagia; Eleni Karapanagiotou; Adrianni Charpidou; Kaliopi D Dilana; Efthimia Nasothimiou; Kevin J Harrington; Aristidis Polyzos; Konstantinos N Syrigos
The clinical significance of serum markers of bone turnover in NSCLC patients: surveillance, management and prognostic implications.
Anticancer research 2009;29(5):1651-7.
2009: Ersi Voskaridou; Dimitrios Christoulas; Charoula Xirakia; Konstantinos Varvagiannis; Georgios Boutsikas; Antonios Bilalis; Efstathios Kastritis; Athanasios Papatheodorou; Evangelos Terpos
Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration.
Haematologica 2009;94(5):725-8.
2009: Evangelos Terpos; M Teresa Cibeira; Joan Blade; Heinz Ludwig
Management of complications in multiple myeloma.
Seminars in hematology 2009;46(2):176-89.
2009: Evangelos Terpos; Eleni Efstathiou; Dimitrios Christoulas; Maria Roussou; Eirini Katodritou; Meletios-Athanassios Dimopoulos
RANKL inhibition: clinical implications for the management of patients with multiple myeloma and solid tumors with bone metastases.
Expert opinion on biological therapy 2009;9(4):465-79.
2009: Emmanouil Spanoudakis; Ming Hu; Kikkeri Naresh; Evangelos Terpos; Valeria Melo; Alistair Reid; Ioannis Kotsianidis; Saad Abdalla; Amin Rahemtulla; Anastasios Karadimitris
Regulation of multiple myeloma survival and progression by CD1d.
Blood 2009;113(11):2498-507.
2009: Meletios A Dimopoulos; Efstathios Kastritis; Maria Roussou; Evangelos Eleutherakis-Papaiakovou; Magdalini Migkou; Maria Gavriatopoulou; Anna Tassidou; Evangelos Terpos
Rituximab-based treatments in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 2009;9(1):59-61.
2009: Efstathios Kastritis; Konstantinos Zervas; Panagiotis Repoussis; Evridiki Michali; Eirini Katodrytou; Athanasios Zomas; Argiris Simeonidis; Evangelos Terpos; Sossana Delimbassi; Amalia Vassou; Dimitra Gika; Meletios A Dimopoulos
Prognostication in young and old patients with Waldenström's macroglobulinemia: importance of the International Prognostic Scoring System and of serum lactate dehydrogenase.
Clinical lymphoma & myeloma 2009;9(1):50-2.
2009: Evangelos Terpos; Anna Tasidou; Efstathios Kastritis; Evangelos Eleftherakis-Papaiakovou; Maria Gavriatopoulou; Magdalini Migkou; Meletios-Athanassios Dimopoulos
Angiogenesis in Waldenström's macroglobulinemia.
Clinical lymphoma & myeloma 2009;9(1):46-9.
2009: Evangelos Terpos; Eirini Katodritou; Evangelos Tsiftsakis; Efstathios Kastritis; Dimitrios Christoulas; Anastasia Pouli; Eurydiki Michalis; Evgenia Verrou; Konstantinos Anargyrou; Konstantinos Tsionos; Meletios A Dimopoulos; Konstantinos Zervas
Cystatin-C is an independent prognostic factor for survival in multiple myeloma and is reduced by bortezomib administration.
Haematologica 2009;94(3):372-9.
2009: Magda Migkou; Meletios-Athanassios Dimopoulos; Maria Gavriatopoulou; Evangelos Terpos
Applications of monoclonal antibodies for the treatment of hematological malignancies.
Expert opinion on biological therapy 2009;9(2):207-20.
2009: Amin Rahemtulla; Evangelos Terpos
Hodgkin's lymphoma.
Clinical evidence 2009;2009():.
2009: Pierre P Major; Richard J Cook; Allan Lipton; Matthew R Smith; Evangelos Terpos; Robert E Coleman
Natural history of malignant bone disease in breast cancer and the use of cumulative mean functions to measure skeletal morbidity.
BMC cancer 2009;9():272.
2008: Efstathios Kastritis; Alexandros Katoulis; Evangelos Terpos; Ioannis Panayiotides; Maria Gavriatopoulopu; Meletios A Dimopopoulos
Schnitzler's syndrome: increased levels of bone formation and angiogenesis factors are reduced after successful pefloxacin treatment.
Clinical lymphoma & myeloma 2008;8(6):359-62.
2008: Evangelos Terpos
Bortezomib directly inhibits osteoclast function in multiple myeloma: implications into the management of myeloma bone disease.
Leukemia research 2008;32(11):1646-7.
2008: Robert Coleman; Janet Brown; Evangelos Terpos; Allan Lipton; Matthew R Smith; Richard Cook; Pierre Major
Bone markers and their prognostic value in metastatic bone disease: clinical evidence and future directions.
Cancer treatment reviews 2008;34(7):629-39.
2008: Evangelos Terpos; Ersi Voskaridou
Interactions between osteoclasts, osteoblasts and immune cells: implications for the pathogenesis of bone loss in thalassemia.
Pediatric endocrinology reviews : PER 2008;6 Suppl 1():94-106.
2008: Ersi Voskaridou; Evangelos Terpos
Pathogenesis and management of osteoporosis in thalassemia.
Pediatric endocrinology reviews : PER 2008;6 Suppl 1():86-93.
2008: Evangelos Terpos; Meletios-Athanassios Dimopoulos
Genetic predisposition for the development of ONJ.
Blood 2008;112(7):2596-7.
2008: Ersi Voskaridou; Dimitrios Christoulas; Marialena Konstantinidou; Evangelos Tsiftsakis; Panagiotis Alexakos; Evangelos Terpos
Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial.
Haematologica 2008;93(10):1588-90.
2008: Eirini Katodritou; Evgenia Verrou; Christina Hadjiaggelidou; Vassiliki Gastari; Konstantinos Laschos; Loukas Kontovinis; Dimitrios Kapetanos; Nikos Constantinou; Evangelos Terpos; Konstantinos Zervas
Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma.
American journal of hematology 2008;83(9):697-701.
2008: Ashraf Badros; Olga Goloubeva; Evangelos Terpos; Todd Milliron; Maria R Baer; Elizabeth A Streeten
Prevalence and significance of vitamin D deficiency in multiple myeloma patients.
British journal of haematology 2008;142(3):492-4.
2008: Allan Lipton; Richard Cook; Fred Saad; Pierre Major; Patrick Garnero; Evangelos Terpos; Janet E Brown; Robert E Coleman
Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid.
Cancer 2008;113(1):193-201.
2008: Eirini Katodritou; Konstantinos Zervas; Evangelos Terpos; Carlo Brugnara
Use of erythropoiesis stimulating agents and intravenous iron for cancer and treatment-related anaemia: the need for predictors and indicators of effectiveness has not abated.
British journal of haematology 2008;142(1):3-10.
2008: Eirini Katodritou; Evgenia Verrou; Vassiliki Gastari; Christina Hadjiaggelidou; Evangelos Terpos; Konstantinos Zervas
Response of primary plasma cell leukemia to the combination of bortezomib and dexamethasone: do specific cytogenetic and immunophenotypic characteristics influence treatment outcome?
Leukemia research 2008;32(7):1153-6.
2008: Jan Sterz; Ivana von Metzler; Jens Claus Hahne; Britta Lamottke; Jessica Rademacher; Ulrike Heider; Evangelos Terpos; Orhan Sezer
The potential of proteasome inhibitors in cancer therapy.
Expert opinion on investigational drugs 2008;17(6):879-95.
2008: Anastasia Pilichou; Ioannis Papassotiriou; Kelly Michalakakou; Smaragdi Fessatou; Emmanuel Fandridis; George Papachristou; Evangelos Terpos
High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis.
Clinical biochemistry 2008;41(9):746-9.
2008: Evangelos Terpos; Maria Roussou; Meletios-Athanassios Dimopoulos
Bortezomib in multiple myeloma.
Expert opinion on drug metabolism & toxicology 2008;4(5):639-54.
2008: Maria Roussou; Efstathios Kastritis; Magdalini Migkou; Erasmia Psimenou; Irini Grapsa; Charis Matsouka; Despina Barmparousi; Evangelos Terpos; Meletios Athanasios Dimopoulos
Treatment of patients with multiple myeloma complicated by renal failure with bortezomib-based regimens.
Leukemia & lymphoma 2008;49(5):890-5.
2008: Evangelos Terpos; Angelos Sarantopoulos; Anna Kouramba; Olga Katsarou; John Stavropoulos; Stavroula Masouridi; Anastasia Karafoulidou; John Meletis
Reduction of CD55 and/or CD59 in red blood cells of patients with HIV infection.
Medical science monitor : international medical journal of experimental and clinical research 2008;14(5):CR276-280.
2008: Konstantinos Anargyrou; Meletios-Athanassios Dimopoulos; Orhan Sezer; Evangelos Terpos
Novel anti-myeloma agents and angiogenesis.
Leukemia & lymphoma 2008;49(4):677-89.
2008: Katerina Zoi; Evangelos Terpos; Christine Zoi; Dimitris Loukopoulos
Increased CD177 (PRV1) expression in thalassaemia and the underlying erythropoietic activity.
British journal of haematology 2008;141(1):100-4.
2008: Giannis Mountzios; Evangelos Terpos; Meletios-Athanassios Dimopoulos
Aurora kinases as targets for cancer therapy.
Cancer treatment reviews 2008;34(2):175-82.
2008: Evangelos Terpos
Have myeloma cells osteoclast-like activity? Implications into the pathogenesis of myeloma bone disease.
Leukemia research 2008;32(4):521-2.
2008: Konstantinos Anargyrou; Evangelos Terpos; Theodoros P Vassilakopoulos; Anastasia Pouli; Sotirios Sachanas; Tatiana Tzenou; Stavroula Masouridis; Dimitrios Christoulas; Maria K Angelopoulou; Evangelia M Dimitriadou; Christina Kalpadakis; Konstantinos Tsionos; Panayiotis Panayiotidis; Meletios A Dimopoulos; Gerassimos A Pangalis; Marie-Christine Kyrtsonis
Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib.
Haematologica 2008;93(3):451-4.
2008: Aristotelis Bamias; Vassiliki Koutsoukou; Evangelos Terpos; Marinos L Tsiatas; Christina Liakos; Ourania E Tsitsilonis; Alexandros Rodolakis; Zannis Voulgaris; George Vlahos; Theoharis Papageorgiou; George V Papatheodoridis; Athanasios Archimandritis; Aris Antsaklis; Meletios A Dimopoulos
Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Gynecologic oncology 2008;108(2):421-7.
2008: Ersi Voskaridou; Dimitrios Christoulas; Lito Antoniadou; Evangelos Terpos
Continuous increase in erythropoietic activity despite the improvement in bone mineral density by zoledronic acid in patients with thalassemia intermedia-induced osteoporosis.
Acta haematologica 2008;119(1):40-4.
2007: Meletios A Dimopoulos; VASSILIS SOULIOTIS; Athanasios Anagnostopoulos; Christina Bamia; Anastasia Pouli; Ioannis Baltadakis; Evangelos Terpos; Soterios A Kyrtopoulos; Petros P Sfikakis
Melphalan-induced DNA damage in vitro as a predictor for clinical outcome in multiple myeloma.
Haematologica 2007;92(11):1505-12.
2007: Efstathios Kastritis; Athanasios Anagnostopoulos; Maria Roussou; Savvas T Toumanidis; Constantinos Pamboukas; Magdalini Migkou; Anna Tassidou; Irini Xilouri; Souzana Delibasi; Erasmia Psimenou; Sofia Mellou; Evangelos Terpos; John N Nanas; Meletios A Dimopoulos
Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone.
Haematologica 2007;92(10):1351-8.
2007: Evangelos Terpos; Meletios A Dimopoulos; O Sezer
The effect of novel anti-myeloma agents on bone metabolism of patients with multiple myeloma.
Leukemia 2007;21(9):1875-84.
2007: Evangelos Terpos; Orhan Sezer; Peter Croucher; Meletios A Dimopoulos
Myeloma bone disease and proteasome inhibition therapies.
Blood 2007;110(4):1098-104.
2007: Konstantinos Zervas; Dimitra Mihou; Eirini Katodritou; Anastasia Pouli; C H Mitsouli; Athanasios Anagnostopoulos; Souzana Delibasi; Marie-Christine Kyrtsonis; Nikolaos Anagnostopoulos; Evangelos Terpos; Panagiotis Zikos; Alice Maniatis; Meletios A Dimopoulos
VAD-doxil versus VAD-doxil plus thalidomide as initial treatment for multiple myeloma: results of a multicenter randomized trial of the Greek Myeloma Study Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(8):1369-75.
2007: Meletios A Dimopoulos; Athanasios Anagnostopoulos; Marie-Christine Kyrtsonis; Konstantinos Zervas; Costas Tsatalas; Garyfallia Kokkinis; Panagiotis Repoussis; Argyris Symeonidis; Souzana Delimpasi; Eirini Katodritou; Elisavet-Christine Vervessou; Evridiki Michali; Anastasia Pouli; Dimitra Gika; Amalia Vassou; Evangelos Terpos; Nikolaos Anagnostopoulos; Theofanis Economopoulos; Gerassimos A Pangalis
Primary treatment of Waldenström macroglobulinemia with dexamethasone, rituximab, and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3344-9.
2007: Ersi Voskaridou; George Tsetsos; Antonios Tsoutsias; Evgenia Spyropoulou; Dimitrios Christoulas; Evangelos Terpos
Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations.
Haematologica 2007;92(6):738-43.
2007: Athanasios Anagnostopoulos; Vangelis Eleftherakis-Papaiakovou; Efstathios Kastritis; Konstantinos Tsionos; Aristotelis Bamias; John Meletis; Meletios A Dimopoulos; Evangelos Terpos
Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
British journal of haematology 2007;137(6):560-8.
2007: Eirini Katodritou; Evangelos Terpos; Konstantinos Zervas; Matthaios Speletas; Dimitrios Kapetanos; Charalambos Kartsios; Evgenia Verrou; Anastasia Banti; Smaragda Effraimidou; John Christakis
Hypochromic erythrocytes (%): a reliable marker for recognizing iron-restricted erythropoiesis and predicting response to erythropoietin in anemic patients with myeloma and lymphoma.
Annals of hematology 2007;86(5):369-76.
2007: Evangelos Terpos; Evgenia Verrou; Anastasia Banti; Vassiliki Kaloutsi; Anna Lazaridou; Konstantinos Zervas
Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis.
Leukemia research 2007;31(4):559-62.
2007: Allan Lipton; Richard J Cook; Robert E Coleman; Matthew R Smith; Pierre Major; Evangelos Terpos; James R Berenson
Clinical utility of biochemical markers of bone metabolism for improving the management of patients with advanced multiple myeloma.
Clinical lymphoma & myeloma 2007;7(5):346-53.
2007: Giannis Mountzios; Meletios A Dimopoulos; Aristotelis Bamias; George Papadopoulos; Efstathios Kastritis; Konstantinos Syrigos; George Pavlakis; Evangelos Terpos
Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton.
Acta oncologica (Stockholm, Sweden) 2007;46(2):221-9.
2007: Athanasios G Galanopoulos; Argyris Symeonidis; Alexandra Kourakli; Eleni A Papadaki; Panayiotis Tsaftaridis; Evangelos Terpos; Anthi Aktipi; Paraskevi Roussou; Maria Protopappa; Maria Pappaioannou; Panagiotis Zikos; Mattheos Speletas; Agapi Parcharidou; Nikolaos Laoutaris; Nikolaos Anagnostopoulos; John Meletis; Gerassimos A Pangalis; Nicholas C Zoumbos; Nora Viniou
Prognostic significance of deletion of the long arm of chromosome 20 in patients with myelodysplastic syndrome (MDS): a study of the Greek MDS Study Group.
European journal of haematology 2007;78(1):89-90.
2007: Eirini Katodritou; Matthaios Speletas; Anastasia Pouli; John Tsitouridis; Konstantinos Zervas; Evangelos Terpos
Successful treatment of extramedullary plasmacytoma of the cavernous sinus using a combination of intermediate dose of thalidomide and dexamethasone.
Acta haematologica 2007;117(1):20-3.
2006: Evangelos Terpos
What's new in bone research--anabolics, tissue repair, therapeutic strategies and more.
IDrugs : the investigational drugs journal 2006;9(12):837-40.
2006: Evangelos Terpos; Deborah J Heath; Amin Rahemtulla; Konstantinos Zervas; Andrew Chantry; Athanasios Anagnostopoulos; Anastasia Pouli; Eirini Katodritou; Evgenia Verrou; Elisavet-Christine Vervessou; Meletios A Dimopoulos; Peter I Croucher
Bortezomib reduces serum dickkopf-1 and receptor activator of nuclear factor-kappaB ligand concentrations and normalises indices of bone remodelling in patients with relapsed multiple myeloma.
British journal of haematology 2006;135(5):688-92.
2006: Marianna Politou; Deborah J Heath; Amin Rahemtulla; Richard Szydlo; Athanasios Anagnostopoulos; Meletios A Dimopoulos; Peter I Croucher; Evangelos Terpos
Serum concentrations of Dickkopf-1 protein are increased in patients with multiple myeloma and reduced after autologous stem cell transplantation.
International journal of cancer. Journal international du cancer 2006;119(7):1728-31.
2006: Ersi Voskaridou; Athanasios Anagnostopoulos; Kostas Konstantopoulos; Eleni Stoupa; Evgenia Spyropoulou; Christos Kiamouris; Evangelos Terpos
Zoledronic acid for the treatment of osteoporosis in patients with beta-thalassemia: results from a single-center, randomized, placebo-controlled trial.
Haematologica 2006;91(9):1193-202.
2006: John Meletis; Nora Viniou; Evangelos Terpos
Novel agents for the management of myelodysplastic syndromes.
Medical science monitor : international medical journal of experimental and clinical research 2006;12(9):RA194-206.
2006: Konstantinos Zervas; Evgenia Verrou; Zisis Teleioudis; Konstantinos Vahtsevanos; Anastasia Banti; Dimitra Mihou; Dimitris Krikelis; Evangelos Terpos
Incidence, risk factors and management of osteonecrosis of the jaw in patients with multiple myeloma: a single-centre experience in 303 patients.
British journal of haematology 2006;134(6):620-3.
2006: Meletios A Dimopoulos; Anastasia Pouli; Athanasios Anagnostopoulos; Panagiotis Repoussis; Argyris Symeonidis; Evangelos Terpos; Sosana Delimbasi; Friderikos Tsolakis; Theofanis Economopoulos; Constantinos Zervas
Macrofocal multiple myeloma in young patients: a distinct entity with favorable prognosis.
Leukemia & lymphoma 2006;47(8):1553-6.
2006: Efstathios Kastritis; Evangelos Terpos; Athanasios Anagnostopoulos; Irini Xilouri; Meletios A Dimopoulos
Angiogenetic factors and biochemical markers of bone metabolism in POEMS syndrome treated with high-dose therapy and autologous stem cell support.
Clinical lymphoma & myeloma 2006;7(1):73-6.
2006: Meletios A Dimopoulos; Efstathios Kastritis; Athanasios Anagnostopoulos; Ioannis Melakopoulos; Dimitra Gika; Lia A Moulopoulos; Christina Bamia; Evangelos Terpos; Konstantinos Tsionos; Aristotelis Bamias
Osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates: evidence of increased risk after treatment with zoledronic acid.
Haematologica 2006;91(7):968-71.
2006: Ersi Voskaridou; Eleni Stoupa; Lito Antoniadou; Evangelos Premetis; Kostas Konstantopoulos; Ioannis Papassotiriou; Evangelos Terpos
Osteoporosis and osteosclerosis in sickle cell/beta-thalassemia: the role of the RANKL/osteoprotegerin axis.
Haematologica 2006;91(6):813-6.
2006: Ersi Voskaridou; Evangelos Terpos; S Michail; Eugenia Hantzi; Athanasios Anagnostopoulos; Alexandra Margeli; D Simirloglou; Dimitris Loukopoulos; Ioannis Papassotiriou
Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia.
Kidney international 2006;69(11):2037-42.
2006: Evangelos Terpos; Vangelis Eleutherakis-Papaiakovou; Meletios A Dimopoulos
Clinical implications of chromosomal abnormalities in multiple myeloma.
Leukemia & lymphoma 2006;47(5):803-14.
2006: Evangelos Terpos; Athanasios Anagnostopoulos; Efstathios Kastritis; Aristotelis Bamias; Konstantinos Tsionos; Meletios A Dimopoulos
Abnormal bone remodelling and increased levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) in Waldenström macroglobulinaemia.
British journal of haematology 2006;133(3):301-4.
2006: Derville O'Shea; Chrissy Giles; Evangelos Terpos; Jolanta B Perz; Marianna Politou; V Sana; Kikkeri N Naresh; Irvin A Lampert; D Samson; S Narat; Edward Kanfer; Eduardo Olavarria; Jane F Apperley; Amin Rahemtulla
Predictive factors for survival in myeloma patients who undergo autologous stem cell transplantation: a single-centre experience in 211 patients.
Bone marrow transplantation 2006;37(8):731-7.
2006: Meletios A Dimopoulos; Athanasios Anagnostopoulos; Evangelos Terpos; Panagiotis Repoussis; Athanasios Zomas; Eirini Katodritou; Marie-Christine Kyrtsonis; Souzana Delibasi; Amalia Vassou; Anastasia Pouli; Konstantinos Zervas; Nikolaos Anagnostopoulos; Alice Maniatis
Primary treatment with pulsed melphalan, dexamethasone and thalidomide for elderly symptomatic patients with multiple myeloma.
Haematologica 2006;91(2):252-4.
2006: Marianna Politou; Anastasios Karadimitris; Evangelos Terpos; Ioannis Kotsianidis; Jane F Apperley; Amin Rahemtulla
No evidence of mutations of the PSMB5 (beta-5 subunit of proteasome) in a case of myeloma with clinical resistance to Bortezomib.
Leukemia research 2006;30(2):240-1.
2006: Amin Rahemtulla; Evangelos Terpos
Hodgkin's lymphoma.
Clinical evidence 2006;2006():.
2006: Giannis Mountzios; George Pavlakis; Evangelos Terpos; George H Sakorafas; Kyriakos Revelos; Aristotelis Bamias; Nikolaos Nikolaou; Pantelis Papasavas; Jean-Charles Soria; Meletios A Dimopoulos
Concurrent development of testicular seminoma and choriocarcinoma of the superior mediastinum, presented as cervical mass: a case report and implications about pathogenesis of germ-cell tumours.
BMC clinical pathology 2006;6():8.
2006: Evangelos Terpos
Biochemical markers of bone metabolism in multiple myeloma.
Cancer treatment reviews 2006;32 Suppl 1():15-9.
2006: George Pavlakis; Giannis Mountzios; Evangelos Terpos; A Leivaditou; George Papadopoulos; P Papasavas
Recurrent ovarian cancer metastatic to the sternum, costae, and thoracic wall after prolonged treatment with platinum-based chemotherapy: a case report and review of the literature.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2006;16 Suppl 1():299-303.
2005: Aristotelis Bamias; Efstathios Kastritis; Christina Bamia; Lia A Moulopoulos; Ioannis Melakopoulos; George Bozas; Vassiliki Koutsoukou; Dimitra Gika; Athanasios Anagnostopoulos; Christos Papadimitriou; Evangelos Terpos; Meletios A Dimopoulos
Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(34):8580-7.
2005: Evangelos Terpos; Marianna Politou; Nora Viniou; Amin Rahemtulla
Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma.
Leukemia & lymphoma 2005;46(12):1699-707.
2005: Evangelos Terpos; Katayoun Rezvani; Supratik Basu; Alison E Milne; Peter E Rose; Geoffrey L Scott; Amin Rahemtulla; Diana Samson; Jane F Apperley
Plasmacytoma relapses in the absence of systemic progression post-high-dose therapy for multiple myeloma.
European journal of haematology 2005;75(5):376-83.
2005: Evangelos Terpos; Dimitra Mihou; Richard Szydlo; K Tsimirika; Christos Karkantaris; Marianna Politou; Ersi Voskaridou; Amin Rahemtulla; Meletios A Dimopoulos; Konstantinos Zervas
The combination of intermediate doses of thalidomide with dexamethasone is an effective treatment for patients with refractory/relapsed multiple myeloma and normalizes abnormal bone remodeling, through the reduction of sRANKL/osteoprotegerin ratio.
Leukemia 2005;19(11):1969-76.
2005: Amy V Jones; Sebastian Kreil; Katerina Zoi; Katherine Waghorn; Claire Curtis; Lingyan Zhang; Joannah Score; Rachel Seear; Andrew Chase; Francis H Grand; Helen White; Christine Zoi; Dimitris Loukopoulos; Evangelos Terpos; Elisavet-Christine Vervessou; Beate Schultheis; Michael Emig; Thomas Ernst; Eva Lengfelder; Rüdiger Hehlmann; Andreas Hochhaus; David Oscier; Richard T Silver; Andreas Reiter; Nicholas C P Cross
Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.
Blood 2005;106(6):2162-8.
2005: Evangelos Terpos; Meletios A Dimopoulos
Myeloma bone disease: pathophysiology and management.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(8):1223-31.
2005: Despina Mavrogianni; Panayiotis Tsaftaridis; Evangelos Terpos; Argyris Symeonidis; Athanasios Galanopoulus; Eleni A Papadaki; Nicholas C Zoumbos; John Meletis; Gerassimos A Pangalis; Nora Viniou
Macrophage Inflammatory Protein-1 alpha (MIP-1alpha) is over-expressed in a cohort of patients with myelodysplastic syndromes.
European journal of haematology 2005;75(1):85-6.
2005: Ersi Voskaridou; Maroussa Douskou; Evangelos Terpos; Alexandra Stamoulakatou; John Meletis; Akis Ourailidis; Ioannis Papassotiriou; Dimitris Loukopoulos
Deferiprone as an oral iron chelator in sickle cell disease.
Annals of hematology 2005;84(7):434-40.
2005: Evangelos Terpos; Amin Rahemtulla; Meletios A Dimopoulos
Current treatment options for myeloma.
Expert opinion on pharmacotherapy 2005;6(7):1127-42.
2005: Evangelos Terpos; Marianna Politou; Amin Rahemtulla
The role of markers of bone remodeling in multiple myeloma.
Blood reviews 2005;19(3):125-42.
2005: Ersi Voskaridou; Evangelos Terpos
Osteoprotegerin to soluble receptor activator of nuclear factor kappa-B ligand ratio is reduced in patients with thalassaemia-related osteoporosis who receive vitamin D3.
European journal of haematology 2005;74(4):359-61.
2005: George K Anagnostopoulos; George H Sakorafas; Panagiotis Kostopoulos; George Margantinis; Stavros Tsiakos; Evangelos Terpos; George Pavlakis; Paul Fortun; Dimitrios Arvanitidis
Disseminated colon cancer with severe peripheral blood eosinophilia and elevated serum levels of interleukine-2, interleukine-3, interleukine-5, and GM-CSF.
Journal of surgical oncology 2005;89(4):273-5.
2005: Marianna Politou; Kikkeri N Naresh; Evangelos Terpos; Danielle Crawley; Irvin A Lampert; Jane F Apperley; Amin Rahemtulla
Anti-angiogenic effect of bortezomib in patients with multiple myeloma.
Acta haematologica 2005;114(3):170-3.
2004: Evdoxia Hatjiharissi; Evangelos Terpos; Mary Papaioannou; C Hatjileontis; Vassiliki Kaloutsi; G Galaktidou; Grigoris Gerotziafas; John Christakis; Konstantinos Zervas
The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
Hematological oncology 2004;22(4):159-68.
2004: Evangelos Terpos; Stamatios Theocharis; Fotios Panitsas; Theodoros Philippidis; Epaminondas Kotronis; Christos Karkantaris
Autoimmune hemolytic anemia with myelodysplastic features followed by bilateral adrenal non-hodgkin lymphoma: a case report and review of the literature.
Leukemia & lymphoma 2004;45(11):2333-8.
2004: Ersi Voskaridou; Evangelos Terpos
New insights into the pathophysiology and management of osteoporosis in patients with beta thalassaemia.
British journal of haematology 2004;127(2):127-39.
2004: Evangelos Terpos; Marianna Politou; Amin Rahemtulla
Tumour lysis syndrome in multiple myeloma after bortezomib (VELCADE) administration.
Journal of cancer research and clinical oncology 2004;130(10):623-5.
2004: Ersi Voskaridou; Maroussa Douskou; Evangelos Terpos; Ioannis Papassotiriou; Alexandra Stamoulakatou; Akis Ourailidis; Afroditi Loutradi; Dimitris Loukopoulos
Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease.
British journal of haematology 2004;126(5):736-42.
2004: Marianna Politou; Evangelos Terpos; Athanasios Anagnostopoulos; Richard Szydlo; Michael A Laffan; Mark Layton; Jane F Apperley; Meletios A Dimopoulos; Amin Rahemtulla
Role of receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin and macrophage protein 1-alpha (MIP-1a) in monoclonal gammopathy of undetermined significance (MGUS).
British journal of haematology 2004;126(5):686-9.
2004: Evangelos Terpos; Marianna Politou; Richard Szydlo; Elisabet Nadal; S Avery; Eduardo Olavarria; Edward Kanfer; John M Goldman; Jane F Apperley; Amin Rahemtulla
Autologous stem cell transplantation normalizes abnormal bone remodeling and sRANKL/osteoprotegerin ratio in patients with multiple myeloma.
Leukemia 2004;18(8):1420-6.
2004: Evangelos Terpos; Amin Rahemtulla
Bisphosphonate treatment for multiple myeloma.
Drugs of today (Barcelona, Spain : 1998) 2004;40(1):29-40.
2003: Evangelos Terpos; Marianna Politou; Amin Rahemtulla
New insights into the pathophysiology and management of bone disease in multiple myeloma.
British journal of haematology 2003;123(5):758-69.
2003: Evangelos Terpos; Michael Samarkos; Christos Meletis; Effie Apostolidou; Maria Tsironi; Konstantinos Korovesis; Despina Mavrogianni; Nora Viniou; John Meletis
Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma.
International journal of hematology 2003;78(4):344-8.
2003: Ersi Voskaridou; Evangelos Terpos; Giovanna Spina; John Palermos; Amin Rahemtulla; Afroditi Loutradi; Dimitris Loukopoulos
Pamidronate is an effective treatment for osteoporosis in patients with beta-thalassaemia.
British journal of haematology 2003;123(4):730-7.
2003: Evangelos Terpos; Marianna Politou; Richard Szydlo; John M Goldman; Jane F Apperley; Amin Rahemtulla
Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma.
British journal of haematology 2003;123(1):106-9.
2003: Evangelos Terpos; Josu de la Fuente; Richard Szydlo; Evdoxia Hatjiharissi; Nora Viniou; John Meletis; Xenophon Yataganas; John M Goldman; Amin Rahemtulla
Tartrate-resistant acid phosphatase isoform 5b: a novel serum marker for monitoring bone disease in multiple myeloma.
International journal of cancer. Journal international du cancer 2003;106(3):455-7.
2003: Evangelos Terpos; Richard Szydlo; Jane F Apperley; Evdoxia Hatjiharissi; Marianna Politou; John Meletis; Nora Viniou; Xenophon Yataganas; John M Goldman; Amin Rahemtulla
Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index.
Blood 2003;102(3):1064-9.
2003: John Meletis; Evangelos Terpos
Recent insights into the pathophysiology of paroxysmal nocturnal hemoglobinuria.
Medical science monitor : international medical journal of experimental and clinical research 2003;9(7):RA161-72.
2003: Meletios A Dimopoulos; Anastasia Pouli; Konstantinos Zervas; Vassiliki Grigoraki; Argyris Symeonidis; Panagiotis Repoussis; Chrisanthi Mitsouli; C Papanastasiou; Dimitris Margaritis; A Tokmaktsis; I Katodritou; Garoufalia Kokkini; Evangelos Terpos; N Vyniou; Michalis Tzilianos; A Chatzivassili; Marie-Christine Kyrtsonis; Panayiotis Panayiotidis; Alice Maniatis
Prospective randomized comparison of vincristine, doxorubicin and dexamethasone (VAD) administered as intravenous bolus injection and VAD with liposomal doxorubicin as first-line treatment in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(7):1039-44.
2003: Vassiliki Kalotychou; Katerina Antonatou; Revekka Tzanetea; Evangelos Terpos; Dimitris Loukopoulos; Yannis Rombos
Analysis of the A(TA)(n)TAA configuration in the promoter region of the UGT1 A1 gene in Greek patients with thalassemia intermedia and sickle cell disease.
Blood cells, molecules & diseases 2003;31(1):38-42.
2003: Salem Akel; Despina Mavroyanni; Xenophon Yataganas; Evangelos Terpos; John Meletis; Konstantinos Anargyrou; Niki Stavrogianni; Gerassimos A Pangalis; Dimitris Loukopoulos; Nora Viniou
Clonal analysis of granulocyte-monocyte colony-forming unit cells with the human androgen receptor gene in chronic myeloid leukemia.
International journal of hematology 2003;77(5):476-81.
2003: Evangelos Terpos; Jane F Apperley; D Samson; Chrissy Giles; Charles Crawley; Edward Kanfer; Eduardo Olavarria; John M Goldman; Amin Rahemtulla
Autologous stem cell transplantation in multiple myeloma: improved survival in nonsecretory multiple myeloma but lack of influence of age, status at transplant, previous treatment and conditioning regimen. A single-centre experience in 127 patients.
Bone marrow transplantation 2003;31(3):163-70.
2003: Evangelos Terpos; Nora Viniou; Josu de la Fuente; John Meletis; Ersi Voskaridou; Christos Karkantaris; George Vaiopoulos; John Palermos; Xenophon Yataganas; John M Goldman; Amin Rahemtulla
Pamidronate is superior to ibandronate in decreasing bone resorption, interleukin-6 and beta 2-microglobulin in multiple myeloma.
European journal of haematology 2003;70(1):34-42.
2003: Penelope Korkolopoulou; Nora Viniou; Nikolaos Kavantzas; Efstratios Patsouris; Irene Thymara; Petros M Pavlopoulos; Evangelos Terpos; Kostas Stamatopoulos; Eleni Plata; Konstantinos Anargyrou; Athina Androulaki; Panagiotis Davaris; Xenophon Yataganas
Clinicopathologic correlations of bone marrow angiogenesis in chronic myeloid leukemia: a morphometric study.
Leukemia 2003;17(1):89-97.
2002: Evangelos Terpos; Athina Mougiou; Alexandra Kouraklis; Aria Chatzivassili; Evridiki Michalis; Nikolaos C Giannakoulas; Eleni Manioudaki; Anna Lazaridou; Vassiliki Bakaloudi; Maria Protopappa; Dimitra Liapi; Elisavet Grouzi; Agapi Parcharidou; Argyris Symeonidis; Garoufalia Kokkini; Nikolaos Laoutaris; George Vaipoulos; Nikolaos Anagnostopoulos; John Christakis; John Meletis; Konstantinos L Bourantas; Nicholas C Zoumbos; Xenophon Yataganas; Nora Viniou
Prolonged administration of erythropoietin increases erythroid response rate in myelodysplastic syndromes: a phase II trial in 281 patients.
British journal of haematology 2002;118(1):174-80.
2002: Despina Mavrogianni; Nora Viniou; Evridiki Michali; Evangelos Terpos; John Meletis; George Vaiopoulos; Marina Madzourani; Gerassimos A Pangalis; Xenophon Yataganas; Dimitris Loukopoulos
Leukemogenic risk of hydroxyurea therapy as a single agent in polycythemia vera and essential thrombocythemia: N- and K-ras mutations and microsatellite instability in chromosomes 5 and 7 in 69 patients.
International journal of hematology 2002;75(4):394-400.
2002: John Meletis; Evangelos Terpos; Michael Samarkos; Christos Meletis; Effie Apostolidou; Veroniki Komninaka; Konstantinos Anargyrou; Konstantinos Korovesis; Despina Mavrogianni; Eleni Variami; Nora Viniou; Kostas Konstantopoulos
Red cells with paroxysmal nocturnal hemoglobinuria-phenotype in patients with acute leukemia.
Hematology (Amsterdam, Netherlands) 2002;7(2):69-74.
2002: Nora Viniou; Evangelos Terpos; Athanasios Galanopoulos; E Kritikou-Griva; Salem Akel; Evridiki Michalis; Effie Apostolidou; D Georgiadou; Alexandra Kouraklis; Agapi Parcharidou; Garoufalia Kokkini; Argyris Symeonidis; Nikolaos Anagnostopoulos; John Christakis; A Tasiopoulou; Dimitris Loukopoulos; Xenophon Yataganas
Treatment of anemia in low-risk myelodysplastic syndromes with amifostine. In vitro testing of response.
Annals of hematology 2002;81(4):182-6.
2002: Konstantinos Anargyrou; George Vaiopoulos; Evangelos Terpos; Maria Tsironi; Kostas Konstantopoulos; Michael Samarkos; John Meletis
Low dose melphalan is a treatment option in elderly patients with high risk myelodysplastic syndrome or secondary acute myeloblastic leukaemia.
Haematologia 2002;32(2):169-73.
2002: Nora Viniou; Eleni Plata; Evangelos Terpos; Eleni Variami; John Meletis; George Vaiopoulos; Dimitris Loukopoulos; Georgia Chatzidimitriou; Xenophon Yataganas
Danazol therapy for thrombocytopenia in patients with myelodysplastic syndromes.
Acta haematologica 2002;107(4):234-6.
2002: John Meletis; Evangelos Terpos; Michael Samarkos; Christos Meletis; Effie Apostolidou; Veroniki Komninaka; Konstantinos Korovesis; Konstantinos Anargyrou; Olga Benopoulou; Despina Mavrogianni; Eleni Variami; Nora Viniou; Kostas Konstantopoulos
Detection of CD55- and/or CD59-deficient red cell populations in patients with plasma cell dyscrasias.
International journal of hematology 2002;75(1):40-4.
2002: Ersi Voskaridou; Evangelos Terpos; Veroniki Komninaka; Eftyhios Eftyhiadis; Marina Mantzourani; Dimitris Loukopoulos
Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
British journal of haematology 2002;116(1):155-7.
2001: Nora Viniou; Evangelos Terpos; John Rombos; G Vaiopoulos; K Nodaros; Kostas Stamatopoulos; John Meletis; Xenophon Yataganas
Acute myeloid leukemia in a patient with ataxia-telangiectasia: a case report and review of the literature.
Leukemia 2001;15(10):1668-70.
2001: Penelope Korkolopoulou; Effie Apostolidou; Petros M Pavlopoulos; Nikolaos Kavantzas; N Vyniou; Irene Thymara; Evangelos Terpos; Efstratios Patsouris; Xenophon Yataganas; Panagiotis Davaris
Prognostic evaluation of the microvascular network in myelodysplastic syndromes.
Leukemia 2001;15(9):1369-76.
2001: Evangelos Terpos; John Palermos; Nora Viniou; George Vaiopoulos; John Meletis; Xenophon Yataganas
Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment.
Calcified tissue international 2001;68(5):285-90.
2001: John Meletis; Evangelos Terpos; Michael Samarkos; Christos Meletis; Effie Apostolidou; Veroniki Komninaka; Konstantinos Korovesis; Despina Mavrogianni; Dimitrios E Boutsis; Eleni Variami; Nora Viniou; Kostas Konstantopoulos; Dimitris Loukopoulos
Detection of CD55- and/or CD59-deficient red cell populations in patients with lymphoproliferative syndromes.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(1):33-7.
2001: George Vaiopoulos; Evangelos Terpos; Nora Viniou; K Nodaros; John Rombos; Dimitris Loukopoulos
Behcet's disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature.
American journal of hematology 2001;66(1):57-8.
2001: John Meletis; Evangelos Terpos; Michael Samarkos; Christos Meletis; Kostas Konstantopoulos; Veroniki Komninaka; Effie Apostolidou; O Benopoulou; Konstantinos Korovesis; Despina Mavrogianni; Eleni Variami; Xenophon Yataganas; Dimitris Loukopoulos
Detection of CD55 and/or CD59 deficient red cell populations in patients with aplastic anaemia, myelodysplastic syndromes and myeloproliferative disorders.
Haematologia 2001;31(1):7-16.
2001: Ersi Voskaridou; Marie-Christine Kyrtsonis; Evangelos Terpos; M Skordili; I Theodoropoulos; A Bergele; E Diamanti; A Kalovidouris; Afroditi Loutradi; Dimitris Loukopoulos
Bone resorption is increased in young adults with thalassaemia major.
British journal of haematology 2001;112(1):36-41.
2000: Evangelos Terpos; John Palermos; Konstantinos Tsionos; Konstantinos Anargyrou; Nora Viniou; P Papassavas; John Meletis; Xenophon Yataganas
Effect of pamidronate administration on markers of bone turnover and disease activity in multiple myeloma.
European journal of haematology 2000;65(5):331-6.
2000: Evangelos Terpos; Maria K Angelopoulou; Eleni Variami; John Meletis; George Vaiopoulos
Sjögren's syndrome associated with multiple myeloma.
Annals of hematology 2000;79(8):449-51.
2000: George Papanikolaou; Marianna Politou; Evangelos Terpos; S Fourlemadis; Nikos Sakellaropoulos; Dimitris Loukopoulos
Hereditary hemochromatosis: HFE mutation analysis in Greeks reveals genetic heterogeneity.
Blood cells, molecules & diseases 2000;26(2):163-8.
1999: Eleni Variami; Evangelos Terpos; Stephanie Vgenopoulou; G Kanellopoulou; John Meletis
Inflammatory pseudotumor of the spleen: a case report and review of the literature.
Annals of hematology 1999;78(12):560-3.
1998: Kostas Konstantopoulos; Evangelos Terpos; H Prinolakis; Alexandra Kanta; Eleni Variami; G Kanellopoulou; George Vaiopoulos; A Floros; Athina Androulaki; John Meletis
Systemic lupus erythematosus presenting as myelofibrosis.
Haematologia 1998;29(2):153-6.
1998: John Meletis; Michael Samarkos; Spyros Mesogitis; Christos Meletis; Athina Mougiou; Evangelos Terpos; Apostolia-Maria Tsimberidou; Anastasios Andreopoulos; Kostas Konstantopoulos; Dimitris Loukopoulos
Severe aplastic anaemia relapsing during a pregnancy; spontaneous remission following termination.
Haematologia 1998;29(2):147-51.
1997: John Meletis; Evridiki Michali; Michael Samarkos; Kostas Konstantopoulos; Christos Meletis; Evangelos Terpos; Apostolia-Maria Tsimberidou; E Chandrinou; Nora Viniou; Yannis Rombos; Gerassimos A Pangalis; Xenophon Yataganas; Dimitris Loukopoulos
Detection of "PNH red cell" populations in hematological disorders using the Sephacryl Gel Test micro typing system.
Leukemia & lymphoma 1997;28(1-2):177-82.